164 related articles for article (PubMed ID: 28819442)
21. CD44 related stemness maneuvers oral squamous cell carcinoma biology.
Tandon A; Singh NN; Gulati N
Indian J Pathol Microbiol; 2022; 65(2):268-273. PubMed ID: 35435358
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
[TBL] [Abstract][Full Text] [Related]
23. HMGA2-Snai2 axis regulates tumorigenicity and stemness of head and neck squamous cell carcinoma.
Li Z; Wu X; Li J; Yu S; Ke X; Yan T; Zhu Y; Cheng J; Yang J
Exp Cell Res; 2022 Sep; 418(1):113271. PubMed ID: 35764101
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of cancer stem cell markers and pro-inflammatory cytokine IL-1β in the oral squamous cell carcinoma and oral submucosal fibrosis.
Awasthi S; Ahmad S; Gupta R; Iqbal MS; Ahmad A
Int J Health Sci (Qassim); 2023; 17(6):28-38. PubMed ID: 37929238
[TBL] [Abstract][Full Text] [Related]
25. Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with interferon-alpha in renal cell carcinoma cell lines.
Ikemoto S; Sugimura K; Yoshida N; Kuratsukuri K; Wada S; Nakatani T
Urol Int; 2004; 73(4):348-53. PubMed ID: 15604581
[TBL] [Abstract][Full Text] [Related]
26. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
[TBL] [Abstract][Full Text] [Related]
27. MSX2 represses tumor stem cell phenotypes within oral squamous cell carcinomas via SOX2 degradation.
Keyimu R; Tuerdi M; Zhao Z
Exp Biol Med (Maywood); 2021 Dec; 246(24):2660-2670. PubMed ID: 34435915
[TBL] [Abstract][Full Text] [Related]
28. Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes.
Erfani E; Roudi R; Rakhshan A; Sabet MN; Shariftabrizi A; Madjd Z
Int J Biol Markers; 2016 Feb; 31(1):e53-61. PubMed ID: 26391478
[TBL] [Abstract][Full Text] [Related]
29. Effect of melatonin supplementation in combination with neoadjuvant chemotherapy to miR-210 and CD44 expression and clinical response improvement in locally advanced oral squamous cell carcinoma: a randomized controlled trial.
Kartini D; Taher A; Panigoro SS; Setiabudy R; Jusman SW; Haryana SM; Abdullah M; Rustamadji P; Purwanto DJ; Sutandyo N; Suroyo I; Siregar BH; Maruli H; Sungkar S
J Egypt Natl Canc Inst; 2020 Feb; 32(1):12. PubMed ID: 32372215
[TBL] [Abstract][Full Text] [Related]
30. The challenge of tumor heterogeneity--different phenotypes of cancer stem cells in a head and neck squamous cell carcinoma xenograft mouse model.
Geißler C; Hambek M; Leinung M; Diensthuber M; Gassner D; Stöver T; Wagenblast J
In Vivo; 2012; 26(4):593-8. PubMed ID: 22773573
[TBL] [Abstract][Full Text] [Related]
31. Bone mesenchymal stem cells are recruited via CXCL8-CXCR2 and promote EMT through TGF-β signal pathways in oral squamous carcinoma.
Meng L; Zhao Y; Bu W; Li X; Liu X; Zhou D; Chen Y; Zheng S; Lin Q; Liu Q; Sun H
Cell Prolif; 2020 Aug; 53(8):e12859. PubMed ID: 32588946
[TBL] [Abstract][Full Text] [Related]
32. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
Wang X; Li H; Shi J
Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of CD44 and TGF-B Expression in Oral Carcinogenesis.
Ghazi N; Saghravanian N; Taghi Shakeri M; Jamali M
J Dent (Shiraz); 2021 Mar; 22(1):33-40. PubMed ID: 33681421
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
[TBL] [Abstract][Full Text] [Related]
35. LncRNA XIST promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by downregulating miR-27b-3p.
Ma SQ; Wang YC; Li Y; Li XY; Yang J; Sheng YM
J Biol Regul Homeost Agents; 2020; 34(6):1993-2001. PubMed ID: 33191714
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma.
Tavares MO; Milan TM; Bighetti-Trevisan RL; Leopoldino AM; de Almeida LO
J Oral Pathol Med; 2022 Jul; 51(6):529-537. PubMed ID: 35678235
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo characterization of cancer stem cell subpopulations in oral squamous cell carcinoma.
Amôr NG; Buzo RF; Ortiz RC; Lopes NM; Saito LM; Mackenzie IC; Rodini CO
J Oral Pathol Med; 2021 Jan; 50(1):52-59. PubMed ID: 32816395
[TBL] [Abstract][Full Text] [Related]
38. circ_0005379 inhibits the progression of oral squamous cell carcinoma by regulating the miR-17-5p/acyl-CoA oxidase 1 axis.
Zhou HX; Wang LY; Chen S; Wang DD; Fang Z
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Aug; 39(4):425-433. PubMed ID: 34409798
[TBL] [Abstract][Full Text] [Related]
39. Effects of 5-ALA mediated photodynamic therapy in oral cancer stem cells.
Pinto MAF; Ferreira CBR; de Lima BES; Molon ÂC; Ibarra AMC; Cecatto RB; Dos Santos Franco AL; Rodrigues MFSD
J Photochem Photobiol B; 2022 Oct; 235():112552. PubMed ID: 36088836
[TBL] [Abstract][Full Text] [Related]
40. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
Xu Q; Zhang Q; Ishida Y; Hajjar S; Tang X; Shi H; Dang CV; Le AD
Oncotarget; 2017 Feb; 8(6):9557-9571. PubMed ID: 27926487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]